Dear LingVitae shareholder

Below you will find various articles and links that is considered helpful and relevant to you as an investor in LingVitae. We hope that this information can contribute to providing you with a broader picture of the industry and the company that you have invested in.

Pacific Bio lifts the veil on its high-speed genome-sequencing effort

Competition to analyze human genomes faster and cheaper — a subject which has been discussed at length here and here — keeps heating up. The latest shot came yesterday, when Menlo Park, Calif.-based Pacific Biosciences granted the NYT an exclusive look at technology it says should eventually make it possible to sequence a genome in just a few minutes for under $1,000.

The latest shot came yesterday, when Menlo Park, Calif.-based Pacific Biosciences granted the NYT an exclusive look at technology it says should eventually make it possible to sequence a genome in just a few minutes for under $1,000.